These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Gene therapy and tissue engineering for sports medicine. Huard J; Li Y; Peng H; Fu FH J Gene Med; 2003 Feb; 5(2):93-108. PubMed ID: 12539148 [TBL] [Abstract][Full Text] [Related]
5. Gene therapy applications for spine fusion. Cha CW; Boden SD Spine (Phila Pa 1976); 2003 Aug; 28(15 Suppl):S74-84. PubMed ID: 12897478 [TBL] [Abstract][Full Text] [Related]
6. The effects of lentiviral gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats. Miyazaki M; Sugiyama O; Tow B; Zou J; Morishita Y; Wei F; Napoli A; Sintuu C; Lieberman JR; Wang JC J Spinal Disord Tech; 2008 Jul; 21(5):372-9. PubMed ID: 18600149 [TBL] [Abstract][Full Text] [Related]
7. Current concepts in gene therapy of the musculoskeletal system. Ivković A; Pascher A; Hudetz D; Jelić M; Haspl M; Windhager R; Pećina M Acta Chir Orthop Traumatol Cech; 2006 Apr; 73(2):115-22. PubMed ID: 16735009 [TBL] [Abstract][Full Text] [Related]
13. Comparison of lentiviral and adenoviral gene therapy for spinal fusion in rats. Miyazaki M; Sugiyama O; Zou J; Yoon SH; Wei F; Morishita Y; Sintuu C; Virk MS; Lieberman JR; Wang JC Spine (Phila Pa 1976); 2008 Jun; 33(13):1410-7. PubMed ID: 18475244 [TBL] [Abstract][Full Text] [Related]
14. Systemic administration of naked DNA: gene transfer to skeletal muscle. Liu F; Liang KW; Huang L Mol Interv; 2001 Aug; 1(3):168-72. PubMed ID: 14993350 [TBL] [Abstract][Full Text] [Related]
15. Gene therapy and tissue engineering in orthopaedic surgery. Musgrave DS; Fu FH; Huard J J Am Acad Orthop Surg; 2002; 10(1):6-15. PubMed ID: 11809046 [TBL] [Abstract][Full Text] [Related]
16. Lack of toxicity of alpha-sarcoglycan overexpression supports clinical gene transfer trial in LGMD2D. Rodino-Klapac LR; Lee JS; Mulligan RC; Clark KR; Mendell JR Neurology; 2008 Jul; 71(4):240-7. PubMed ID: 18525034 [TBL] [Abstract][Full Text] [Related]
17. Bone morphogenetic protein gene therapy using a fibrin scaffold for a rabbit spinal-fusion experiment. Lee TC; Ho JT; Hung KS; Chen WF; Chung YH; Yang YL Neurosurgery; 2006 Feb; 58(2):373-80; discussion 373-80. PubMed ID: 16462492 [TBL] [Abstract][Full Text] [Related]
18. Musculoskeletal gene therapy and its potential use in the treatment of complicated musculoskeletal infection. Shen W; Li Y; Huard J Infect Dis Clin North Am; 2005 Dec; 19(4):1007-22. PubMed ID: 16297745 [TBL] [Abstract][Full Text] [Related]
19. Factoring nonviral gene therapy into a cure for hemophilia A. Gabrovsky V; Calos MP Curr Opin Mol Ther; 2008 Oct; 10(5):464-70. PubMed ID: 18830922 [TBL] [Abstract][Full Text] [Related]
20. Muscle stem cells can act as antigen-presenting cells: implication for gene therapy. Cao B; Bruder J; Kovesdi I; Huard J Gene Ther; 2004 Sep; 11(17):1321-30. PubMed ID: 15175641 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]